Chase Coleman - Tiger Global Management
Holding/activity history for Eli Lilly & Co. (LLY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | 0 | 0.00 | Sell 100.00% | 3.46 | SEC | ||
| 2025 Q2 | 1,511,160 | 3.46 | Add 13.20% | 0.40 | $779.53 | $1,177,994,555 | SEC |
| 2025 Q1 | 1,334,960 | 4.15 | Add 1.91% | 0.08 | $825.91 | $1,102,556,814 | SEC |
| 2024 Q4 | 1,309,960 | 3.82 | Add 35.08% | 0.99 | $772.00 | $1,011,289,120 | SEC |
| 2024 Q3 | 969,800 | 3.67 | Add 4.28% | 0.15 | $885.94 | $859,184,612 | SEC |
| 2024 Q2 | 930,000 | 3.89 | Add 4.49% | 0.17 | $905.38 | $842,003,400 | SEC |
| 2024 Q1 | 890,000 | 3.78 | $777.96 | $692,384,400 | SEC | ||
| 2023 Q4 | 890,000 | 3.69 | Reduce 3.17% | 0.12 | $582.92 | $518,798,800 | SEC |
| 2023 Q3 | 919,100 | 3.64 | Add 26.93% | 0.77 | $537.13 | $493,676,183 | SEC |
| 2023 Q2 | 724,100 | 2.85 | Buy | 2.85 | $468.98 | $339,588,418 | SEC |